Skip to main content
Erschienen in: Inflammation 5/2011

01.10.2011

Acute Lung Inflammation in Klebsiella pneumoniae B5055-Induced Pneumonia and Sepsis in BALB/c Mice: A Comparative Study

verfasst von: Vijay Kumar, Sanjay Chhibber

Erschienen in: Inflammation | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Lungs play an important role in the body's defense against a variety of pathogens, but this network of immune system-mediated defense can be deregulated during acute pulmonary infections. The present study compares acute lung inflammation occurring during Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB/c mice. Pneumonia was induced by intranasal instillation of bacteria (104 cfu), while sepsis was developed by placing the fibrin-thrombin clot containing known amount of bacteria (102 cfu) into the peritoneal cavity of animals. Mice with sepsis showed 100% mortality within five post-infection days, whereas all the animals with pneumonia survived. In animals suffering from K. pneumoniae B5055-induced pneumonia, all the inflammatory parameters (TNF-α, IL-1α, MPO, MDA, and NO) were found to be maximum till third post-infection day, after that, a decline was observed, whereas in septic animals, all the above-mentioned markers of inflammation kept on increasing. Histopathological study showed presence of alternatively activated alveolar macrophages (or foam cells) in lungs of mice with pneumonia after third post-infection day, which might have contributed to the induction of resolution of inflammation, but no such observation was made in lungs of septic mice. Hence, during pneumonia, controlled activation of macrophages may lead to resolution of inflammation.
Literatur
1.
Zurück zum Zitat Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334–1349.PubMedCrossRef Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334–1349.PubMedCrossRef
2.
Zurück zum Zitat Sesler, C.N., G.L. Bloomfield, and A.A. Fowler. 1996. Current concepts of sepsis and acute lung injury. Clinics in Chest Medicine 17: 213–235.CrossRef Sesler, C.N., G.L. Bloomfield, and A.A. Fowler. 1996. Current concepts of sepsis and acute lung injury. Clinics in Chest Medicine 17: 213–235.CrossRef
3.
Zurück zum Zitat Weiland, J.E., W.B. Davis, J.F. Holter, J.R. Mohammed, P.M. Dorinsky, and J.E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance. The American Review of Respiratory Disease 133: 218–235.PubMed Weiland, J.E., W.B. Davis, J.F. Holter, J.R. Mohammed, P.M. Dorinsky, and J.E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance. The American Review of Respiratory Disease 133: 218–235.PubMed
4.
Zurück zum Zitat Bernard, J.W., M.G. Biro, S.K. Lo, S. Ohno, M.A. Caroza, M. Moyle, H.R. Soule, and A.B. Malik. 1995. Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. Journal of Immunology 155: 4876–4881. Bernard, J.W., M.G. Biro, S.K. Lo, S. Ohno, M.A. Caroza, M. Moyle, H.R. Soule, and A.B. Malik. 1995. Neutrophil inhibitory factor prevents neutrophil-dependent lung injury. Journal of Immunology 155: 4876–4881.
5.
Zurück zum Zitat DeMarsh, P.L., G.I. Wells, T.F. Lewandowski, C.L. Frey, P.K. Bhatnagar, and E.J.R. Ostovic. 1996. Treatment of experimental gram-negative and gram positive bacterial sepsis with the hemoregulatory peptide SK&F 107647. The Journal of Infectious Diseases 173: 203–211.PubMedCrossRef DeMarsh, P.L., G.I. Wells, T.F. Lewandowski, C.L. Frey, P.K. Bhatnagar, and E.J.R. Ostovic. 1996. Treatment of experimental gram-negative and gram positive bacterial sepsis with the hemoregulatory peptide SK&F 107647. The Journal of Infectious Diseases 173: 203–211.PubMedCrossRef
6.
Zurück zum Zitat Toky, V., S. Sharma, B.B. Arora, and S. Chhibber. 2003. Establishment of sepsis model following implantation of Klebsiella pneumoniae-infected fibrin clot into the peritoneal cavity of mice. Folia Microbiologica 48(5): 665–669.PubMedCrossRef Toky, V., S. Sharma, B.B. Arora, and S. Chhibber. 2003. Establishment of sepsis model following implantation of Klebsiella pneumoniae-infected fibrin clot into the peritoneal cavity of mice. Folia Microbiologica 48(5): 665–669.PubMedCrossRef
7.
Zurück zum Zitat Held, T.K., M.E.A. Mielke, M. Chedid, M. Unger, M. Trautman, D. Huhn, and A.S. Cross. 1998. Granulocyte colony-stimulating factor worsens the outcome the outcome of the experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91: 2525–2533.PubMed Held, T.K., M.E.A. Mielke, M. Chedid, M. Unger, M. Trautman, D. Huhn, and A.S. Cross. 1998. Granulocyte colony-stimulating factor worsens the outcome the outcome of the experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91: 2525–2533.PubMed
8.
Zurück zum Zitat Yadav, V., S. Sharma, K. Harjai, H. Mohan, and S. Chhibber. 2003. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in the mice. Indian Journal of Medical Research 118: 47–52.PubMed Yadav, V., S. Sharma, K. Harjai, H. Mohan, and S. Chhibber. 2003. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in the mice. Indian Journal of Medical Research 118: 47–52.PubMed
9.
Zurück zum Zitat Greenberger, M.J., R.M. Strieter, S.L. Kunkel, J.M. Danforth, R.E. Goodman, and T.J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. Journal of Immunology 155: 722–729. Greenberger, M.J., R.M. Strieter, S.L. Kunkel, J.M. Danforth, R.E. Goodman, and T.J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. Journal of Immunology 155: 722–729.
10.
Zurück zum Zitat Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.PubMedCrossRef Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.PubMedCrossRef
11.
Zurück zum Zitat Tsai, W.C., R.M. Strieter, D.A. Zisman, J.M. Wilkowski, K.A. Bucknell, G. Chen, and T.J. Standiford. 1997. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infection and Immunity 65: 1870–1875.PubMed Tsai, W.C., R.M. Strieter, D.A. Zisman, J.M. Wilkowski, K.A. Bucknell, G. Chen, and T.J. Standiford. 1997. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infection and Immunity 65: 1870–1875.PubMed
12.
Zurück zum Zitat Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 133: 913–927. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 133: 913–927.
13.
Zurück zum Zitat Chabot, F., J.A. Mitchell, J.M. Gutteridge, and T.W. Evans. 1998. Reactive oxygen species in acute lung injury. The European Respiratory Journal 11: 745–757.PubMed Chabot, F., J.A. Mitchell, J.M. Gutteridge, and T.W. Evans. 1998. Reactive oxygen species in acute lung injury. The European Respiratory Journal 11: 745–757.PubMed
14.
Zurück zum Zitat Rabinovici, R., P.J. Bugelski, K. Eesser, L.M. Hillegass, J. Vernick, and G. Feuerstein. 1993. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. Journal of Applied Physiology 74: 1791–1802.PubMed Rabinovici, R., P.J. Bugelski, K. Eesser, L.M. Hillegass, J. Vernick, and G. Feuerstein. 1993. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. Journal of Applied Physiology 74: 1791–1802.PubMed
15.
Zurück zum Zitat Goya, T., M. Abe, H. Shimura, and M. Torisu. 1992. Characteristics of alveolar macrophages in experimental septic lung. Journal of Leukocyte Biology 52: 236–243.PubMed Goya, T., M. Abe, H. Shimura, and M. Torisu. 1992. Characteristics of alveolar macrophages in experimental septic lung. Journal of Leukocyte Biology 52: 236–243.PubMed
16.
Zurück zum Zitat Harris, S.E., S. Nelson, C.L. Astry, B.G. Bainton, and W.R. Summer. 1988. Endotoxin-induced suppression of pulmonary antibacterial defenses against Staphylococcus aureus. The American Review of Respiratory Disease 138: 1439–1443.PubMed Harris, S.E., S. Nelson, C.L. Astry, B.G. Bainton, and W.R. Summer. 1988. Endotoxin-induced suppression of pulmonary antibacterial defenses against Staphylococcus aureus. The American Review of Respiratory Disease 138: 1439–1443.PubMed
17.
Zurück zum Zitat Frevert, C.W., A.E. Warner, E. Weller, and J.D. Brain. 1998. The effect of endotoxin on in vivo rat alveolar macrophage phagocytosis. Experimental Lung Research 24: 745–758.PubMedCrossRef Frevert, C.W., A.E. Warner, E. Weller, and J.D. Brain. 1998. The effect of endotoxin on in vivo rat alveolar macrophage phagocytosis. Experimental Lung Research 24: 745–758.PubMedCrossRef
18.
Zurück zum Zitat Jacobs, R.F., D.P. Kiel, and R.A. Balk. 1986. Alveolar macrophage function in a canine model of endotoxin-induced lung injury. The American Review of Respiratory Disease 134: 745–751.PubMed Jacobs, R.F., D.P. Kiel, and R.A. Balk. 1986. Alveolar macrophage function in a canine model of endotoxin-induced lung injury. The American Review of Respiratory Disease 134: 745–751.PubMed
19.
Zurück zum Zitat Reddy, R.C., G.H. Chen, M.W. Newstead, T. Moore, X. Zeng, K. Tateda, and T.J. Standiford. 2001. Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin-10. Infection and immunity 69: 1394–1401.PubMedCrossRef Reddy, R.C., G.H. Chen, M.W. Newstead, T. Moore, X. Zeng, K. Tateda, and T.J. Standiford. 2001. Alveolar macrophage deactivation in murine septic peritonitis: Role of interleukin-10. Infection and immunity 69: 1394–1401.PubMedCrossRef
20.
Zurück zum Zitat Steinhauser, M.L., C.M. Hogaboam, S.I. Kunkel, N.W. Lukacs, R.M. Strieter, and T.J. Standiford. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defence. Journal of Immunology 162: 392–399. Steinhauser, M.L., C.M. Hogaboam, S.I. Kunkel, N.W. Lukacs, R.M. Strieter, and T.J. Standiford. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defence. Journal of Immunology 162: 392–399.
21.
Zurück zum Zitat Deng, J.C., G. Cheng, M.W. Newstead, X. Zeng, K. Kobayashi, R.A. Flavell, and T.J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. Journal of Clinical Investigation 116: 2532–2542.PubMed Deng, J.C., G. Cheng, M.W. Newstead, X. Zeng, K. Kobayashi, R.A. Flavell, and T.J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. Journal of Clinical Investigation 116: 2532–2542.PubMed
22.
Zurück zum Zitat Siracusa, M.C., J.J. Reece, J.F. Urban Jr., and A.L. Scott. 2008. Dynamics of lung macrophage activation in response to helminth infection. Journal of Leukocyte Biology 84: 1422–1433.PubMedCrossRef Siracusa, M.C., J.J. Reece, J.F. Urban Jr., and A.L. Scott. 2008. Dynamics of lung macrophage activation in response to helminth infection. Journal of Leukocyte Biology 84: 1422–1433.PubMedCrossRef
23.
Zurück zum Zitat Murphy, J.E., P.R. Tedbury, S. Homer-Vanniasinkam, J.H. Walker, and S. Ponnambalam. 2005. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182: 1–15.PubMedCrossRef Murphy, J.E., P.R. Tedbury, S. Homer-Vanniasinkam, J.H. Walker, and S. Ponnambalam. 2005. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182: 1–15.PubMedCrossRef
24.
Zurück zum Zitat Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. The Journal of Experimental Medicine 200: 267–272.PubMedCrossRef Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. The Journal of Experimental Medicine 200: 267–272.PubMedCrossRef
25.
Zurück zum Zitat Arredouani, M.S., A. Palecanda, H. Koziel, Y.C. Huang, A. Imrich, T.H. Sulahian, et al. 2005. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. Journal of Immunology 175: 6058–6064. Arredouani, M.S., A. Palecanda, H. Koziel, Y.C. Huang, A. Imrich, T.H. Sulahian, et al. 2005. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. Journal of Immunology 175: 6058–6064.
26.
Zurück zum Zitat Arredouani, M.S., Z. Yang, A. Imrich, Y. Ning, G. Qin, and L. Kobzik. 2006. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. American Journal of Respiratory Cell and Molecular Biology 35: 474–478.PubMedCrossRef Arredouani, M.S., Z. Yang, A. Imrich, Y. Ning, G. Qin, and L. Kobzik. 2006. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. American Journal of Respiratory Cell and Molecular Biology 35: 474–478.PubMedCrossRef
27.
Zurück zum Zitat Nair, M.G., Y. Du, J.G. Perrigoue, C. Zaph, J.J. Taylor, M. Goldschmidt, et al. 2009. Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung. The Journal of Experimental Medicine 206(4): 937–952.PubMedCrossRef Nair, M.G., Y. Du, J.G. Perrigoue, C. Zaph, J.J. Taylor, M. Goldschmidt, et al. 2009. Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung. The Journal of Experimental Medicine 206(4): 937–952.PubMedCrossRef
28.
Zurück zum Zitat Dahl, M., A.K. Bauer, M. Arreduani, R. Soininen, K. Tryggvason, S.R. Kleeberger, and L. Kobzik. 2007. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. Journal of Clinical Investigation 117: 757–764.PubMedCrossRef Dahl, M., A.K. Bauer, M. Arreduani, R. Soininen, K. Tryggvason, S.R. Kleeberger, and L. Kobzik. 2007. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. Journal of Clinical Investigation 117: 757–764.PubMedCrossRef
29.
Zurück zum Zitat Ares, M.P.S., M. Stollenwerk, A. Olsson, B. Kallin, S. Jovinge, and J. Nilsson. 2002. Decreased inducibility of TNF expression in lipid-loaded macrophages. BMC Immunology 3: 13–22.PubMedCrossRef Ares, M.P.S., M. Stollenwerk, A. Olsson, B. Kallin, S. Jovinge, and J. Nilsson. 2002. Decreased inducibility of TNF expression in lipid-loaded macrophages. BMC Immunology 3: 13–22.PubMedCrossRef
30.
Zurück zum Zitat Broug-Holub, E., G.B. Toews, Freek, I. Van, J. Waarden, R.M. Streiter, S.L. Kunkel, R. Paine III, and T.J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infection and Immunity 65(4): 1139–1146.PubMed Broug-Holub, E., G.B. Toews, Freek, I. Van, J. Waarden, R.M. Streiter, S.L. Kunkel, R. Paine III, and T.J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infection and Immunity 65(4): 1139–1146.PubMed
31.
Zurück zum Zitat Hashimoto, S., J.-F. Pittet, K. Hong, H. Folkesson, G. Bagby, L. Kobzik, C. Frevert, K. Watanabe, S. Tsurufuji, and J. Wiener-Kronish. 1996. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. The American Journal of Physiology 270: 819–828. Hashimoto, S., J.-F. Pittet, K. Hong, H. Folkesson, G. Bagby, L. Kobzik, C. Frevert, K. Watanabe, S. Tsurufuji, and J. Wiener-Kronish. 1996. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. The American Journal of Physiology 270: 819–828.
32.
Zurück zum Zitat Morimoto, K., H. Amano, F. Sonoda, M. Baba, M. Senba, H. Yoshimine, H. Yamamoto, T. Ii, K. Oishi, and T. Nagatake. 2001. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. American Journal of Respiratory Cell and Molecular Biology 24: 608–615.PubMed Morimoto, K., H. Amano, F. Sonoda, M. Baba, M. Senba, H. Yoshimine, H. Yamamoto, T. Ii, K. Oishi, and T. Nagatake. 2001. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. American Journal of Respiratory Cell and Molecular Biology 24: 608–615.PubMed
Metadaten
Titel
Acute Lung Inflammation in Klebsiella pneumoniae B5055-Induced Pneumonia and Sepsis in BALB/c Mice: A Comparative Study
verfasst von
Vijay Kumar
Sanjay Chhibber
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2011
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9253-9

Weitere Artikel der Ausgabe 5/2011

Inflammation 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.